| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-07 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |